Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus? The action for health in diabetes (Look AHEAD) study

Gordon S. Huggins, George D. Papandonatos, Bahar Erar, Ligia Belalcazar, Ariel Brautbar, Christie Ballantyne, Abbas E. Kitabchi, Lynne E. Wagenknecht, William C. Knowler, Henry J. Pownall, Rena R. Wing, Inga Peter, Jeanne M. McCaffery

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background-High-density lipoprotein cholesterol (HDL-C) and triglycerides are cardiovascular risk factors susceptible to lifestyle behavior modification and genetics. We hypothesized that genetic variants identified by genome-wide association studies as associated with HDL-C or triglyceride levels modify 1-year treatment response to an intensive lifestyle intervention, relative to a usual care of diabetes mellitus support and education. Methods and Results-We evaluated 82 single-nucleotide polymorphisms, which represent 31 loci demonstrated by genome-wide association studies to be associated with HDL-C and triglycerides, in 3561 participants who consented for genetic studies and met eligibility criteria. Variants associated with higher baseline HDL-C levels, cholesterol ester transfer protein (CETP) rs3764261 and hepatic lipase (LIPC) rs8034802, were found to be associated with HDL-C increases with intensive lifestyle intervention (P=0.0038 and 0.013, respectively) and had nominally significant treatment interactions (P=0.047 and 0.046, respectively). The fatty acid desaturase-2 rs1535 variant, associated with low baseline HDL-C (P=0.017), was associated with HDL-C increases with intensive lifestyle intervention (0.0037) and had a nominal treatment interaction (P=0.035). Apolipoprotein B (rs693) and LIPC (rs8034802) single-nucleotide polymorphisms showed nominally significant associations with HDL-C and triglyceride changes with intensive lifestyle intervention and a treatment interaction (P<0.05). Phosphatidylglycerophosphate synthase-1 single-nucleotide polymorphisms (rs4082919) showed the most significant triglyceride treatment interaction in the full cohort (P=0.0009). Conclusions-This is the first study to identify genetic variants modifying lipid responses to a randomized lifestyle behavior intervention in overweight or obese individuals with diabetes mellitus. The effects of genetic factors on lipid changes may differ from the effects on baseline lipids and are modifiable by behavioral intervention.

Original languageEnglish (US)
Pages (from-to)391-399
Number of pages9
JournalCirculation: Cardiovascular Genetics
Volume6
Issue number4
DOIs
StatePublished - Aug 2013

Fingerprint

Type 2 Diabetes Mellitus
HDL Cholesterol
Life Style
Obesity
Health
Single Nucleotide Polymorphism
Genome-Wide Association Study
CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase
Lipids
Diabetes Mellitus
Fatty Acid Desaturases
Cholesterol Ester Transfer Proteins
lipoprotein triglyceride
Behavior Therapy
Apolipoproteins B
Lipase
Triglycerides
Education
Liver

Keywords

  • Behavior therapy
  • Cholesterylester transfer
  • Genomics
  • Lipoproteins
  • Physiological protein genetics
  • Triglycerides

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Genetics(clinical)
  • Genetics

Cite this

Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus? The action for health in diabetes (Look AHEAD) study. / Huggins, Gordon S.; Papandonatos, George D.; Erar, Bahar; Belalcazar, Ligia; Brautbar, Ariel; Ballantyne, Christie; Kitabchi, Abbas E.; Wagenknecht, Lynne E.; Knowler, William C.; Pownall, Henry J.; Wing, Rena R.; Peter, Inga; McCaffery, Jeanne M.

In: Circulation: Cardiovascular Genetics, Vol. 6, No. 4, 08.2013, p. 391-399.

Research output: Contribution to journalArticle

Huggins, Gordon S. ; Papandonatos, George D. ; Erar, Bahar ; Belalcazar, Ligia ; Brautbar, Ariel ; Ballantyne, Christie ; Kitabchi, Abbas E. ; Wagenknecht, Lynne E. ; Knowler, William C. ; Pownall, Henry J. ; Wing, Rena R. ; Peter, Inga ; McCaffery, Jeanne M. / Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus? The action for health in diabetes (Look AHEAD) study. In: Circulation: Cardiovascular Genetics. 2013 ; Vol. 6, No. 4. pp. 391-399.
@article{2b730266117d49b7be5f0c4e9237f531,
title = "Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus? The action for health in diabetes (Look AHEAD) study",
abstract = "Background-High-density lipoprotein cholesterol (HDL-C) and triglycerides are cardiovascular risk factors susceptible to lifestyle behavior modification and genetics. We hypothesized that genetic variants identified by genome-wide association studies as associated with HDL-C or triglyceride levels modify 1-year treatment response to an intensive lifestyle intervention, relative to a usual care of diabetes mellitus support and education. Methods and Results-We evaluated 82 single-nucleotide polymorphisms, which represent 31 loci demonstrated by genome-wide association studies to be associated with HDL-C and triglycerides, in 3561 participants who consented for genetic studies and met eligibility criteria. Variants associated with higher baseline HDL-C levels, cholesterol ester transfer protein (CETP) rs3764261 and hepatic lipase (LIPC) rs8034802, were found to be associated with HDL-C increases with intensive lifestyle intervention (P=0.0038 and 0.013, respectively) and had nominally significant treatment interactions (P=0.047 and 0.046, respectively). The fatty acid desaturase-2 rs1535 variant, associated with low baseline HDL-C (P=0.017), was associated with HDL-C increases with intensive lifestyle intervention (0.0037) and had a nominal treatment interaction (P=0.035). Apolipoprotein B (rs693) and LIPC (rs8034802) single-nucleotide polymorphisms showed nominally significant associations with HDL-C and triglyceride changes with intensive lifestyle intervention and a treatment interaction (P<0.05). Phosphatidylglycerophosphate synthase-1 single-nucleotide polymorphisms (rs4082919) showed the most significant triglyceride treatment interaction in the full cohort (P=0.0009). Conclusions-This is the first study to identify genetic variants modifying lipid responses to a randomized lifestyle behavior intervention in overweight or obese individuals with diabetes mellitus. The effects of genetic factors on lipid changes may differ from the effects on baseline lipids and are modifiable by behavioral intervention.",
keywords = "Behavior therapy, Cholesterylester transfer, Genomics, Lipoproteins, Physiological protein genetics, Triglycerides",
author = "Huggins, {Gordon S.} and Papandonatos, {George D.} and Bahar Erar and Ligia Belalcazar and Ariel Brautbar and Christie Ballantyne and Kitabchi, {Abbas E.} and Wagenknecht, {Lynne E.} and Knowler, {William C.} and Pownall, {Henry J.} and Wing, {Rena R.} and Inga Peter and McCaffery, {Jeanne M.}",
year = "2013",
month = "8",
doi = "10.1161/CIRCGENETICS.113.000042",
language = "English (US)",
volume = "6",
pages = "391--399",
journal = "Circulation. Genomic and precision medicine",
issn = "1942-325X",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "4",

}

TY - JOUR

T1 - Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus? The action for health in diabetes (Look AHEAD) study

AU - Huggins, Gordon S.

AU - Papandonatos, George D.

AU - Erar, Bahar

AU - Belalcazar, Ligia

AU - Brautbar, Ariel

AU - Ballantyne, Christie

AU - Kitabchi, Abbas E.

AU - Wagenknecht, Lynne E.

AU - Knowler, William C.

AU - Pownall, Henry J.

AU - Wing, Rena R.

AU - Peter, Inga

AU - McCaffery, Jeanne M.

PY - 2013/8

Y1 - 2013/8

N2 - Background-High-density lipoprotein cholesterol (HDL-C) and triglycerides are cardiovascular risk factors susceptible to lifestyle behavior modification and genetics. We hypothesized that genetic variants identified by genome-wide association studies as associated with HDL-C or triglyceride levels modify 1-year treatment response to an intensive lifestyle intervention, relative to a usual care of diabetes mellitus support and education. Methods and Results-We evaluated 82 single-nucleotide polymorphisms, which represent 31 loci demonstrated by genome-wide association studies to be associated with HDL-C and triglycerides, in 3561 participants who consented for genetic studies and met eligibility criteria. Variants associated with higher baseline HDL-C levels, cholesterol ester transfer protein (CETP) rs3764261 and hepatic lipase (LIPC) rs8034802, were found to be associated with HDL-C increases with intensive lifestyle intervention (P=0.0038 and 0.013, respectively) and had nominally significant treatment interactions (P=0.047 and 0.046, respectively). The fatty acid desaturase-2 rs1535 variant, associated with low baseline HDL-C (P=0.017), was associated with HDL-C increases with intensive lifestyle intervention (0.0037) and had a nominal treatment interaction (P=0.035). Apolipoprotein B (rs693) and LIPC (rs8034802) single-nucleotide polymorphisms showed nominally significant associations with HDL-C and triglyceride changes with intensive lifestyle intervention and a treatment interaction (P<0.05). Phosphatidylglycerophosphate synthase-1 single-nucleotide polymorphisms (rs4082919) showed the most significant triglyceride treatment interaction in the full cohort (P=0.0009). Conclusions-This is the first study to identify genetic variants modifying lipid responses to a randomized lifestyle behavior intervention in overweight or obese individuals with diabetes mellitus. The effects of genetic factors on lipid changes may differ from the effects on baseline lipids and are modifiable by behavioral intervention.

AB - Background-High-density lipoprotein cholesterol (HDL-C) and triglycerides are cardiovascular risk factors susceptible to lifestyle behavior modification and genetics. We hypothesized that genetic variants identified by genome-wide association studies as associated with HDL-C or triglyceride levels modify 1-year treatment response to an intensive lifestyle intervention, relative to a usual care of diabetes mellitus support and education. Methods and Results-We evaluated 82 single-nucleotide polymorphisms, which represent 31 loci demonstrated by genome-wide association studies to be associated with HDL-C and triglycerides, in 3561 participants who consented for genetic studies and met eligibility criteria. Variants associated with higher baseline HDL-C levels, cholesterol ester transfer protein (CETP) rs3764261 and hepatic lipase (LIPC) rs8034802, were found to be associated with HDL-C increases with intensive lifestyle intervention (P=0.0038 and 0.013, respectively) and had nominally significant treatment interactions (P=0.047 and 0.046, respectively). The fatty acid desaturase-2 rs1535 variant, associated with low baseline HDL-C (P=0.017), was associated with HDL-C increases with intensive lifestyle intervention (0.0037) and had a nominal treatment interaction (P=0.035). Apolipoprotein B (rs693) and LIPC (rs8034802) single-nucleotide polymorphisms showed nominally significant associations with HDL-C and triglyceride changes with intensive lifestyle intervention and a treatment interaction (P<0.05). Phosphatidylglycerophosphate synthase-1 single-nucleotide polymorphisms (rs4082919) showed the most significant triglyceride treatment interaction in the full cohort (P=0.0009). Conclusions-This is the first study to identify genetic variants modifying lipid responses to a randomized lifestyle behavior intervention in overweight or obese individuals with diabetes mellitus. The effects of genetic factors on lipid changes may differ from the effects on baseline lipids and are modifiable by behavioral intervention.

KW - Behavior therapy

KW - Cholesterylester transfer

KW - Genomics

KW - Lipoproteins

KW - Physiological protein genetics

KW - Triglycerides

UR - http://www.scopus.com/inward/record.url?scp=84884510827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884510827&partnerID=8YFLogxK

U2 - 10.1161/CIRCGENETICS.113.000042

DO - 10.1161/CIRCGENETICS.113.000042

M3 - Article

C2 - 23861364

AN - SCOPUS:84884510827

VL - 6

SP - 391

EP - 399

JO - Circulation. Genomic and precision medicine

JF - Circulation. Genomic and precision medicine

SN - 1942-325X

IS - 4

ER -